ArticlePDF Available

Successful Treatment of Subungual Warts With Pulsed Dye Laser: Report of Four Cases

Wiley
Journal of Cosmetic Dermatology
Authors:
1 of 3
Journal of Cosmetic Dermatology, 2025; 24:e16756
https://doi.org/10.1111/jocd.16756
Journal of Cosmetic Dermatology
LETTER OPEN ACCESS
Successful Treatment of Subungual Warts With Pulsed Dye
Laser: Report of Four Cases
ShuangLyu1,2 | ZhenhuaYue1,2 | HuiminZhang1, 2 | Xi'anFu1,2 | HongLiu1,2 | FurenZhang1,2
1Hospital for Skin Disea ses, Shandong First Medical University, Jinan, Shandong Province, China | 2Shandong Provincial Institute of Dermatology and
Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong Province, China
Correspondence: Xi'an F u (f19830827@126.com) | Hong Liu (hongyue2519@hotmail.com)
Received: 5 November 2024 | Revised: 12 December 2024 | Accepted: 16 December 2024
Funding: This work was supported by the Central guidance for local scientific and technological development projects of Shandong Province
(YDZ X2023058), Shandong Provincial Medical and Health Development Project (202320 000621).
Keywords: laser therapy| pulsed dye laser| subungual warts
To the Editor,
Warts are caused by the human papilloma virus (HPV) and have
a considerable impact on quality of life due to pain and embar-
rassment [1]. Treatment of warts requires multiple destructive
procedures, but results are often unsatisfactory. Subungual
warts affecting the nail folds can be painful and interrupt daily
activities. Destructive treatments require disruption of the nail
plate to access the lesion, increasing the risk of injury to the sub-
ungual wedge, underlying bone, or nail matrix [2]. Finding less
invasive and painless therapies for subungual warts is a chal-
lenge for clinicians. Conventional methods include drawbacks
such as scar development, a lengthy recovery period, and a high
recurrence rate; they may also result in nail plate damage, se-
vere pain, and even nail atrophy [2]. In contrast, pulsed dye laser
(PDL) has a low incidence of pain, with only temporary pain and
residual hyperpigmentation, making it a safe, tolerable and rela-
tively effective treatment [3, 4]. We present four cases of subun-
gual warts treated with PDL.
Report of Cases
Four patients had subungual warts: one female and three males
aged 9–40. All four patients had previously undergone cryo-
therapy, which caused significant pain and was ineffective. The
patients were treated with PDL (595 nm, Candela, Israel). Cases
1–4 are presented in Table 1. Clinical pictures were collected
before and after each therapy and were followed up (Figure1).
After cessation of treatment, the lesions achieved long- term re-
mission without nail damage and did not recur during the fol-
low- up period.
Discussion
Warts have been found to respond favorably to PDL [5]. PDL's
therapeutic techniques involve the breakdown of the wart-
supplying capillaries, which results in host cell death. It can also
trigger an immunological response and cause IL- 2 and IL- 4 to
be upregulated within the lesion. Furthermore, PDL destroys
the virus itself due to its susceptibility to heat [3–5].
The type of warts, laser parameters, number of treatment ses-
sions, and treatment intervals are associated with the success
rate of PDL treatments [4, 5]. A retrospective study treating 227
warts patients with PDL found that up to 6 sessions with inter-
vals of 3–4 weeks apart and a fluence of 12.5–15.0 J/cm2 had the
best efficacy [5]. Another study showed that higher success rates
were associated with higher flow settings (9.5 J/cm2) and also an
increased number of sessions (up to 6) at 3–4 week intervals [4].
Park etal. have reported that there was no significant difference
in lesion clearance between 2- and 3- week treatment intervals
[3]. Our patient 1 was healed after just two treatments with a
one- week gap, indicating that shorter treatment intervals could
This is a n open access ar ticle under the terms of t he Creative Commons Attr ibution License, which p ermits use, dis tribution and repro duction in any medium, p rovided the orig inal work is
properly cited.
© 2025 T he Author(s). Journal of Cosm etic Dermat ology publishe d by Wiley Periodic als LLC.
Xi'an F u and Hong Liu are the joint c orresponding a uthors of this art icle.
2 of 3 Journal of Cosmetic Dermatology, 2025
be more effective and reduce the number of sessions. The mean
length of treatment in our patients was 4.1 months and the mean
number of sessions was 4.5. Notably, patient 4 received 8 treat-
ments, which may be attributed to individual differences, dis-
ease duration, and lesion thickness.
PDL appears to eliminate warts only while sparing the sur-
rounding nail plate, causing transient pain similar to that of a
rubber band snapping [6]. Our patient 4 was a 9- year- old boy
who fully tolerated the pain of PDL treatment. PDL is a relatively
safe procedure with acceptable side effects [3], produces satisfac-
tory results in cosmetically sensitive areas, and has little effect
on daily activities.
The high cost of PDL and the requirement of multiple treat-
ments may result in patients or clinicians choosing it less fre-
quently. However, due to the special location of subungual
warts, traditional cryotherapy can be affected by the nail and
significantly painful. In conclusion, PDL is an option for sub-
ungual warts, especially in children who cannot tolerate pain.
This report illustrates the advantages of PDL for the treatment
of subungual warts, provides references for treatment parame-
ters and frequency, and provides evidence on effectiveness and
safety. However, in clinical practice, attempts have been made
to combine it with other treatment modalities (e.g., superficial X-
ray therapy, photodynamic therapy or cryotherapy) to improve
efficacy and reduce recurrence rates. Further studies with larger
sample sizes are still needed.
Author Contributions
Conceived by Furen Zhang, Hong Liu and Xi'an Fu. Collected pho-
tographs by Zhenhua Yue and Huimin Zhang. Written and edited by
Shuang Lyu and Xi'an Fu.
TABLE  | Ca ses introduction.
Patient 1 2 3 4
Age (years) 25 31 40 9
Disease course 1 years 4 months 3 months 3 years
Gender F M M M
Position Left index Right index Left thumb Right thumb, middle finger
and left pointer finger
Parameters 21 J/c m2, 3 ms 21 J /cm2, 3 ms 21 J/cm 2, 3 m s 23 J/cm2, 3 ms
(energy, pulse width)
No. of sessions 2 4 4 8
Inter vala1 we ek 3– 4 weeks 4 we eks 2 we eks
Follow- up (months) 20 month s 3 months 4 months 5 months
Previous treatments (failed
therapy)
Cryotherapy Cr yotherapy Cryotherapy Cryotherapy
Adverse reaction Immediate pain Immediate pain Immediate pain Immediate pain
aInterval: time between each session of treatment.
FIGUR E  | Clinical images before PDL treatment and at f inal follow- up. Patient 1: A, G; Patient 2: B, H; Patient 3: C, I; Patient 4: Right thumb (D,
J), middle finger (E, K) and left pointer finger (F, L).
3 of 3
Acknowledgments
We thank all the patients who participated and the doctors who pro-
vided cases.
Ethics Statement
Patients provide informed consent, including treatment and disclosure
of case details and images.
Conflicts of Interest
The authors declare no conflicts of interest.
Data Availability Statement
The data that support the findings of this study are available on request
from the corresponding author. The data are not publicly available due
to privacy or ethical restrictions.
ShuangLyu
ZhenhuaYue
HuiminZhang
Xi’anFu
HongLiu
FurenZhang
References
1. G. F. Mohammed, M. S. Al- Dhubaibi, S. S. Bahaj, and A. I. A . Elneam,
“Systemic Immunotherapy for the Treatment of Warts: A Literature
Review,Journal of Cosmetic Dermatology 21, no. 11 (2022): 5532–5536.
2. C . A. Schroeter, L. Ka as, J. J. Waterval, P. M. Bos, and H. A . Neumann,
“Successful Treatment of Periungual Warts Using Photodynamic
Therapy: A Pilot Study,” Journal of the European Academy of
Dermatology and Venereology 21, no. 9 (2007): 1170–1174.
3. H. S. Park and W. S. Choi, “Pulsed Dye Laser Treatment for Viral
Warts: A Study of 12 0 Patients,” Journal of Dermatology 35, no. 8 (2008):
491–498.
4. J. Nguyen, D. Z. Korta, L. W. Chapman, and K. M. Kelly, “Laser
Treatment of Nongenital Verrucae: A Systematic Review,” JAMA
Dermatology 152, no. 9 (2016): 1025–1034.
5. E. E. Sparreboom, H. G. Luijks, H. A. Luiting- Welkenhuyzen, P. W.
Willems, C. P. Groeneveld, and H. J. Bovenschen, “Pulsed- Dye Laser
Treatment for Recalcitrant Viral Warts: A Retrospective Case Series
of 227 Patients,” British Journal of Dermatolog y 171, no. 5 (2014):
1270–1273.
6. H. Je on, L. J. Bernstein, D. A . Belkin, S. Ghal ili, and R. G. Geronemus,
“Pulsed Dye Laser Treatment of Port- Wine Stains in Infancy Without
the Need for General Anesthesia,” JAMA Dermatology 155, no. 4 (2019):
435441.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background: Immunotherapy has emerged as a critical therapeutic tool for the treatment of warts. Immunotherapy for warts is currently restricted to recalcitrant lesions. A small number of regimens appear to be extremely effective. Furthermore, there is a scarcity of evidence-based research. Objective: Furthermore, in the majority of cases, their safety and effectiveness have not been evaluated in double-blind, controlled clinical trials, making the reproducibility of many of the listed treatments difficult to analyze and a possible placebo effect difficult to rule out. Methods: Analyzing and discussing different types of systemic immunotherapy. The different types of immunotherapy for warts are mentioned in this report. Results: Systemic immunotherapeutic modalities commonly used in the treatment Echinacea, propolis, oral retinoids, glycyrrhizinic acid, levamisole, cimetidine, and zinc sulfate have all been reported as effective treatment modalities for different types of warts. Conclusion: Immunotherapy has emerged as one of the most important therapeutic modalities for warts. Such treatment is required not only for recalcitrant or multiple lesions, but also in the majority of treated cases.
Article
Importance Recent concerns regarding repetitive use of general anesthesia in children younger than 3 years have placed greater importance on the controversy surrounding the timing of the initiation of port-wine stain (PWS) laser treatment. Objective To evaluate the use of PWS treatments at the age of 1 year or younger in the office setting without general anesthesia. Design, Setting, and Participants Retrospective cohort study based on medical record reviews at a single, high-volume laser center for children who started pulsed dye laser treatment at the age of 1 year or younger for their PWS between 2000 and 2017. The data cutoff was at 1 year after the initial treatment to have comparable data points. Main Outcomes and Measures The primary outcome was improvement of PWSs using before and after photographs, which were reviewed by 4 physicians independently and graded using the following 5-point visual analog scale (VAS): poor (grade 1: 0%-25% improvement), fair (grade 2: 26%-50% improvement), good (grade 3: 51%-75% improvement), excellent (grade 4: 76%-99% improvement), and complete (grade 5: 100% improvement) clearance. Results Of the 197 patients (73 [37.1%] boys; 124 [62.9%] girls), most (149 [75.6%]) had facial lesions. The mean age at the time of first treatment was 3.38 months (range, 5-355 days) and the mean number of treatments was 9.8 (range, 2-23; median, 10). Per the mean physician VAS grading of 197 patients, 51 patients (25.9%) showed 100% clearance (mean [range] VAS score of 4.78 [4.5 – 5]); 81 patients (41.1%) showed 76 to 99% improvement (mean [range] VAS score of 3.91 [3.5 to <4.5]); 44 patients (22.3%) showed 51% to 75% improvement (mean [range] VAS score of 2.86 [2.5 to <3.5]); 13 patients (6.6%) showed 26% to 50% improvement (mean [range] VAS score of 2.12 [1.5 to <2.5]); and 8 patients (4.1%) showed 0 to 25% improvement (mean [range] VAS score of 0.78 [0 to <1.5]). The presence of a V1 (first branch of the trigeminal nerve [ophthalmic nerve]) lesion was associated with a statistically significantly higher clearance rate by a VAS grade of 0.55 (95% CI, 0.25-0.84; P < .001). The mean (SD) VAS grade for all patients was 3.65 (1.26), corresponding to excellent clearance. None of the patients experienced scarring or permanent pigmentary change. Conclusions and Relevance In this study, treatment of PWSs in infancy was both safe and effective. Early intervention allows for treatment without general anesthesia, maximizing the chance to achieve clearance before school age and thereby minimizing the negative outcome of PWSs for both the patient and the family.
Article
Importance Although cutaneous warts are common lesions, full remission is not always achieved with conventional therapies. Laser modalities including carbon dioxide (CO2), erbium:yttrium-aluminum-garnet (Er:YAG), pulsed dye (PDL), and Nd:YAG have been investigated as alternative treatments for warts. Objective To review the use and efficacy of lasers for treating nongenital cutaneous warts. Evidence Review Published randomized clinical trials (RCTs), cohort studies, case series, and case reports involving laser treatment of nongenital warts were retrieved by searching PubMed with no date limits. Quality ratings of studies were based on a modified version of the Oxford Centre for Evidence-Based Medicine scheme for rating individual studies. A higher emphasis was placed on RCTs and prospective cohort studies with large sample sizes and detailed methodology. Findings There were 35 studies published between 1989 and 2015 that comprised an aggregate of 2149 patients. Simple and recalcitrant nongenital warts treated with lasers show variable response rates (CO2 laser, 50%-100%; Er:YAG laser, 72%-100%; PDL, 47%-100%; and Nd:YAG laser, 46%-100%). Current RCTs suggest that PDL is equivalent to conventional therapies such as cryotherapy and cantharidin. Combination therapies with lasers and other agents including bleomycin, salicylic acid, and light-emitting diode have shown some success. Conclusions and Relevance Lasers can be an effective treatment option for both simple and recalcitrant warts. The lasers most studied for this purpose are CO2, PDL, and Nd:YAG, and of these, PDL has the fewest adverse effects. Currently, use of lasers for wart treatment is limited by lack of established treatment guidelines. Future studies are needed to compare laser modalities with each other and with nonlaser treatment options, and to establish optimal treatment protocols.
Article
Viral warts are a common dermatological problem with a wide variety of treatment options. Recalcitrant warts, not responding to first line therapies, are a frustrating problem with high recurrence rates, painful treatments and only modest treatment results.1 During the last decade pulsed dye laser (PDL) therapy has emerged as a safe and efficacious treatment for these warts, with variable success rates (48-95%).2-12 We summarized treatment outcomes of eleven studies on the treatment of recalcitrant warts with PDL therapy in table 1.This article is protected by copyright. All rights reserved.
Article
A prospective, non-blinded, non-randomized study on 120 wart patients treated with pulsed dye laser was performed to evaluate the efficacy and safety of pulsed dye laser treatment for viral warts and to demonstrate the proper application and effective technique of this method. The overall clearance rate was 49.5%. The clearance rates of flat warts, periungual warts, plantar warts and common warts were 67.6%, 51.1%, 47.6% and 44.3%, respectively. Overall, the response rates of pediatric warts, recalcitrant warts and old warts were superior to those of adult warts, simple warts and non-old warts, respectively; however, those trends were not statistically significant. We concluded that pulsed dye laser treatment is a safe, tolerable and relatively effective treatment method for viral warts. Pulsed dye laser treatment may be a more efficacious method for flat warts and recalcitrant periungual warts, and it can be an effective modality for newly-developed warts. The highest clearance rate was noted at a fluence of 9.5 J/cm2 (P < or = 0.05) and it is recommended that practitioners perform pulsed dye laser treatments for viral warts at the fluences of 9.0-9.5 J/cm2. A replacement of pulsed dye laser treatment should be considered unless prominent improvement is observed after three treatment sessions.
Article
The aim of this pilot study was an investigation on photodynamic therapy (PDT) whether it is a good alternative for treating periungual and subungual warts of the hands. Twenty patients (mean age: 30.5 years) with a total of 40 periungual and subungual warts were treated with PDT. A photosensitizer, 20%delta-aminolevulinic acid was applied on the warts. After a mean incubation time of 4.6 h (SD: 1.2), the warts were irradiated with the VersaLight for 5-30 min (15.2 +/- 4.3 min). After a mean of 4.5 treatments a mean clearance of 100% was achieved in 90% of the patients. One patient (5%) showed a clearance of 50% and another showed no improvement. The subungual or periungual location of the wart had no influence on the number of treatments or end result (P > 0.05). There were two recurrences during the mean follow-up period of 5.9 months (SD: 7.6). Besides mainly pain and hyperpigmentation, most treatments had no side-effects. PDT can offer a good alternative for treating periungual warts of the hands. Larger studies are indicated.